REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients — RESONANCE

Recurrent Pericarditis Clinical Trial

Official title:
Registry of the Natural History of Recurrent Pericarditis in Pediatric and Adult Patients

Status Recruiting

Clinical Trial Summary

The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04687358
Study type	Observational [Patient Registry]
Source	Kiniksa Pharmaceuticals, Ltd.
Contact	JoAnn Clair, PhD
Phone	781-431-9100
Email	jclair@kiniksa.com
Status	Recruiting
Phase
Start date	March 16, 2021
Completion date	February 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05494788` - Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)	Phase 2
Completed	`NCT03737110` - Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis	Phase 3
Completed	`NCT03980522` - A Pilot Study of KPL-914 in Recurrent Pericarditis	Phase 2
Recruiting	`NCT06071156` - Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis	N/A
Not yet recruiting	`NCT05107934` - Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis	Phase 2/Phase 3